Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Angiogenesis Inhibitors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05824481
What this trial is testing

Study of Cadonilimab (AK104) Plus Lenvatinib in Patients With Advanced Endometrial Cancer

Who this might be right for
Endometrial CancerEndometrial Adenocarcinoma
Sun Yat-sen University 32
Testing effectiveness (Phase 2)Ended earlyNCT00722865
What this trial is testing

Avastin (Bevacizumab) Plus Adriamycin, Bleomycin, Vinblastine and Dacarbazine (ABVD) for Advanced Stage Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
Massachusetts General Hospital 25
Testing effectiveness (Phase 2)Study completedNCT00357500
What this trial is testing

Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer

Who this might be right for
Central Nervous System Tumor, PediatricLeukemiaLymphoma+3 more
Dana-Farber Cancer Institute 101
Testing effectiveness (Phase 2)Ended earlyNCT02664961
What this trial is testing

Study of TRC105 and Bevacizumab in Patients With Refractory Gestational Trophoblastic Neoplasia (GTN)

Who this might be right for
Gestational Trophoblastic NeoplasiaChoriocarcinomaPlacental Site Trophoblastic Tumor+1 more
Tracon Pharmaceuticals Inc. 3
Post-approval studies (Phase 4)Study completedNCT01922154
What this trial is testing

Intravitreous Ranibizumab as Adjunctive Treatment for Trabeculectomy in Neovascular Glaucoma

Who this might be right for
Glaucoma, Neovascular
Siriraj Hospital 15
Early research (Phase 1)Study completedNCT00712504
What this trial is testing

Study Of SU011248 In Combination With Docetaxel In Patients With Advanced Cancer

Who this might be right for
Advanced Solid TumorsNon Small Cell Lung Cancer
Pfizer 49
Testing effectiveness (Phase 2)Study completedNCT03417895
What this trial is testing

SHR-1210 Combined With Apatinib in Treatment of ED-SCLC After Failure of First Line Standard Therapy

Who this might be right for
Small-cell Lung Cancer
Jiangsu HengRui Medicine Co., Ltd. 59
Testing effectiveness (Phase 2)UnknownNCT05372198
What this trial is testing

Surufatinib With or Wothout Immunotherapy for Advanced Colorectal Cancer in Later Line

Who this might be right for
Colorectal Neoplasms
Hubei Cancer Hospital 50
Early research (Phase 1)Study completedNCT00030095
What this trial is testing

2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00842335
What this trial is testing

A Phase 1/2, Open-Label, Dose-Escalation Study of JI-101, in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Jubilant Innovation Ltd. 18
Early research (Phase 1)Study completedNCT00727233
What this trial is testing

Sorafenib to Treat Children and Young Adults With Neurofibromatosis Type 1 and Inoperable Plexiform Neurofibromas

Who this might be right for
Neurofibromatosis Type IPlexiform Neurofibroma
National Cancer Institute (NCI) 9
Not applicableEnded earlyNCT04257721
What this trial is testing

Predictive Score For Maxillary Osteonecrosis After Invasive Oral Surgery

Who this might be right for
Osteonecrosis Due to Drugs, Jaw
Centre Hospitalier Sud Francilien 45
Large-scale testing (Phase 3)Active Not RecruitingNCT04704921
What this trial is testing

Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD

Who this might be right for
AMDnAMDWet Age-related Macular Degeneration+6 more
AbbVie 671
Testing effectiveness (Phase 2)Temporarily pausedNCT05036837
What this trial is testing

Infiltration of Medical Ozone for the Treatment of Medication-Related Osteonecrosis of the Jaws (MRONJ)

Who this might be right for
MEDICATION RELATED OSTEONECROSIS OF THE JAW
University of Palermo 50
Not applicableEnded earlyNCT01336231
What this trial is testing

Impact on Quality of Life, Fatigue and Cognitive Function in Anti-angiogenesis in Patients With Metastatic Kidney Cancer

Who this might be right for
Metastatic Kidney Cancer
Centre Francois Baclesse 82
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06063070
What this trial is testing

First-line Maintenance Treatment With Fluzoparib Plus Bevacizumab in Advanced BRCA Wild Type Ovarian Cancer

Who this might be right for
Ovarian CancerHigh Grade Serous Adenocarcinoma of OvaryHigh Grade Endometrioid Ovarian Cancer+2 more
Sun Yat-sen University 44
Testing effectiveness (Phase 2)Looking for participantsNCT06976944
What this trial is testing

Pembrolizumab + Paclitaxel +/- Bevacizumab for Triple-negative Breast Cancer

Who this might be right for
Recurrent Triple-Negative Breast Cancer
Yukinori Ozaki 24
Testing effectiveness (Phase 2)Study completedNCT00355238
What this trial is testing

A Phase II Open Label Study of BMS-582664 in Locally Advanced or Metastatic Hepatocellular Cancer

Who this might be right for
Hepatocellular Carcinoma (HCC)
Bristol-Myers Squibb 137
Large-scale testing (Phase 3)UnknownNCT02350361
What this trial is testing

Endostar Combination With Chemotherapy and EGFR-TKI in Lung Cancer Rechallenging Treatment After Acquired Resistance.

Who this might be right for
Lung Cancer
Peking University Third Hospital 60
Early research (Phase 1)Study completedNCT00390156
What this trial is testing

Imatinib, Bevacizumab, and Cyclophosphamide in Patients With Refractory Metastatic Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor
University of California, San Francisco 35
Next Page